ASCO GU: Amgen’s Lumakras posts encouraging results in pancreatic cancer, though not as dazzling as Mirati rival
ASCO GU: Amgen’s Lumakras posts encouraging results in pancreatic cancer, [...]
Pfizer and Regeneron led pharma’s sales growth in Q4 while Teva, Biogen and Gilead lagged
Pfizer and Regeneron led pharma’s sales growth in Q4 while [...]
Novartis plots 400 job cuts in India after striking sales pact with Dr. Reddy’s
Novartis plots 400 job cuts in India after striking sales [...]
AstraZeneca pledges more Evusheld doses to US, bringing its antibody supply deal to $855M
AstraZeneca pledges more Evusheld doses to US, bringing its antibody [...]
FDA signs off on Lilly’s new antibody drug, bebtelovimab, which is effective against the omicron variant
FDA signs off on Lilly’s new antibody drug, bebtelovimab, which [...]
Pfizer’s and Lilly’s JAK inhibitor safety concerns prompt Europe to scrutinize drug class
Pfizer’s and Lilly’s JAK inhibitor safety concerns prompt Europe to [...]
Pfizer stalls COVID-19 vaccine app as it awaits data on third dose in young kids
Pfizer stalls COVID-19 vaccine app as it awaits data on [...]
FDA sets an example through Eli Lilly, Innovent’s PD-1, rocking the boat for future contenders: analyst
FDA sets an example through Eli Lilly, Innovent’s PD-1, rocking [...]
Ipsen telegraphs $400M deal for consumer healthcare split
Ipsen telegraphs $400M deal for consumer healthcare split fkansteiner Fri, [...]
Lilly back in COVID-19 antibody game with $720 million deal with U.S. for omicron-busting hopeful
Lilly back in COVID-19 antibody game with $720 million deal [...]